French health authorities announced Friday that they have identified 51 patients with monkeypox infections, in line with the increasing global numbers.
The country’s index case was registered in May, and the most recent tally was 33 verified infections on Wednesday.
The United States Centers for Disease Control and Prevention said it is not oblivious of the over seven hundred worldwide monkeypox infections, including twenty-one in the United States.
The French national health agency said all the patients were male from 22 to 63 years old, with one hospitalization and subsequent discharge.
The uncommon illness—which is rarely fatal—is generally characterized by a chickenpox-like rash on the face and hands, exhaustion, fever, shivers, enlarged lymph nodes, and muscular pains.
Monkeypox is endemic in West and Central Africa, but uncommon in North Africa and Europe.
The World Health Organization outlines the typical duration of monkeypox as two to four weeks.
French health authorities announced last week that they did not anticipate an “outbreak,” and that the country had adequate vaccine stores.
If individuals have had direct contact with known infected people, the government of France has suggested they be vaccinated, including health professionals.